FYBOGEL is a long-established fibre-based gastrointestinal medicine brand associated with Reckitt’s healthcare business. It is primarily known for products containing ispaghula husk (also called psyllium husk), a soluble dietary fibre that absorbs water and expands in the intestine. The brand is principally positioned for the relief of constipation and maintenance of normal bowel regularity. 1

Note: FYBOGEL should not be confused with similarly named cosmetic or aesthetic treatments sometimes called “Fybogel” or “Fibrogel.” The FYBOGEL discussed here is the established gastrointestinal/pharmaceutical brand.

FYBOGEL has a relatively long history as a pharmaceutical brand. A UK trademark record shows FYBOGEL was filed by Reckitt Benckiser Health Limited in 1972, with the mark registered for pharmaceutical preparations. 2

The brand subsequently appeared in multiple international trademark jurisdictions. For example, a Canadian FYBOGEL registration dates to 1977, while an EU trademark application was filed in 2004 covering pharmaceutical preparations, fibre-containing foods and fibre drinks.

This makes FYBOGEL notably different from a newly created wellness or dietary-supplement brand: its identity developed within the pharmaceutical and consumer-healthcare sector, with decades of trademark and product history.

FYBOGEL has historically been associated with Reckitt Benckiser, now generally branded simply as Reckitt.

Trademark records identify Reckitt Benckiser Health Limited as the owner of the UK FYBOGEL mark and identify Reckitt Benckiser healthcare entities in other jurisdictions. 3

The brand therefore sits within the broader ecosystem of consumer-health products associated with Reckitt.

The central idea behind FYBOGEL is relatively straightforward:

ispaghula husk → absorbs water → increases stool bulk and moisture → helps promote bowel movement.

Ispaghula is a plant-derived fibre rich in fibre and mucilage. It can absorb substantial quantities of water, causing the material to swell and increase intestinal bulk. This produces a bulk-forming laxative effect rather than the stimulant-laxative mechanism associated with products such as senna.

FYBOGEL is consequently generally used when a person needs additional fibre and wants to relieve or manage constipation.

The signature ingredient of FYBOGEL is ispaghula husk.

Ispaghula comes from the seeds of Plantago ovata. In pharmaceutical terminology, it is classified as a bulk-forming laxative. The fibre absorbs water and swells, increasing the volume of intestinal contents and helping stimulate normal bowel movement.

A standard FYBOGEL sachet formulation, for example, contains approximately 3.5 g of ispaghula husk. The exact formulation and additional ingredients can vary according to product and country.

The FYBOGEL range varies between countries.

FYBOGEL Orange

One of the best-known products is FYBOGEL Orange, a powdered fibre preparation supplied in individual sachets. In Ireland, for example, the product is described as a high-fibre drink containing ispaghula husk and is marketed for constipation relief and maintaining regularity. 4

The Singapore market likewise currently lists FYBOGEL Natural Fibre Drink Sachet Orange Flavour, including 10- and 30-sachet packs. 6

FYBOGEL Hi-Fibre Lemon

Another formulation is FYBOGEL Hi-Fibre Lemon. Its patient information identifies ispaghula husk at 3.5 g per sachet and describes the product as a medicine for constipation. 8

FYBOGEL FibreChews

In some markets, FYBOGEL has expanded beyond traditional drink sachets. The Irish range includes Fybogel FibreChews, a chewable fibre product containing Fibersol-2. It is positioned for constipation relief and maintenance of regularity. 5

This illustrates an important aspect of the modern FYBOGEL brand: while its historical identity is strongly associated with ispaghula fibre sachets, the product portfolio can differ considerably by country.

FYBOGEL belongs to the bulk-forming laxative category.

That distinction is important.

A bulk-forming product primarily works by adding fibre and water to intestinal contents. In contrast, stimulant laxatives such as sennosides work by stimulating intestinal activity.

The broader Reckitt gut-health portfolio illustrates this distinction: its Senokot brand is described as a stimulant laxative, whereas Fybogel is described as a bulk-forming laxative.

FYBOGEL’s positioning can be summarized as:

“Fibre-based, gentle constipation relief and regularity.”

Rather than presenting itself primarily as a general nutritional supplement, FYBOGEL has traditionally occupied the space between dietary fibre and pharmaceutical constipation treatment.

Its key consumer propositions are therefore:

• Fibre-based
• Bulk-forming
• For constipation relief
• Supports regular bowel function
• Available in convenient sachet formats
• Long-established pharmaceutical brand

FYBOGEL is not limited to the UK.

Available evidence shows trademark and/or product activity in several markets, including:

• United Kingdom
• Ireland
• Canada
• Australia
• South Africa
• Turkey
• Malta
• Singapore
• Other European markets

However, the exact formulation, regulatory classification, pack size, flavours and indications vary by country. It is therefore misleading to assume that a FYBOGEL product sold in one country is identical to one sold elsewhere.

FYBOGEL has a visible retail presence in Singapore. Watsons Singapore currently lists the brand and offers its Natural Fibre Drink Sachet Orange Flavour in 10- and 30-sachet packs. 6

This places FYBOGEL within Singapore’s consumer-health and pharmacy retail market alongside other gastrointestinal products.

FYBOGEL is fundamentally a medicinal/pharmaceutical brand, rather than simply a food or lifestyle brand.

Its regulatory classification can differ between jurisdictions. For example, UK product documentation describes Fybogel as a medicine containing ispaghula husk, while trademark records cover pharmaceutical and dietary-fibre-related goods.

Consequently, claims about the product should be understood in the context of the specific country’s approved product information.

Because FYBOGEL products contain fibre that absorbs water, adequate fluid intake is important when using ispaghula-based products. Product directions, age restrictions, contraindications and duration of use should be followed according to the package information for the specific product.

For example, the Irish product information says that Fybogel Orange is intended for adults and children over six, while Fybogel FibreChews have different age guidance. 5

This is another reason not to generalize dosage instructions from one country’s FYBOGEL product to another.

From a branding perspective, FYBOGEL is interesting because the name has remained remarkably consistent despite decades of changes in corporate ownership structures, markets and product formats.

The wordmark dates back to at least 1972 in the UK, and FYBOGEL subsequently accumulated trademark registrations in multiple jurisdictions.

Its brand identity is consequently built more around medical familiarity and functional efficacy than around the contemporary “wellness lifestyle” branding common among newer fibre supplements.

FYBOGEL belongs to a broader gastrointestinal-health portfolio. In Ireland, for example, the same consumer-health platform presents Fybogel, Senokot and FyboCalm as different approaches to managing gut symptoms. 7

Conceptually:

This gives FYBOGEL a fairly specific position within the company’s digestive-health portfolio.

FYBOGEL is best understood as a legacy consumer-health pharmaceutical brand centred on plant-derived fibre.

Its significance comes from several factors:

1. Longevity — its UK trademark history reaches back to 1972.
2. Internationalization — the mark has been registered and/or marketed across numerous countries.
3. Clear therapeutic category — it is strongly associated with bulk-forming treatment for constipation.
4. Recognizable active ingredient — ispaghula husk provides the core pharmacological mechanism.
5. Product diversification — modern versions include traditional drink sachets as well as newer formats such as FibreChews.
6. Major consumer-health ownership — the brand has been associated with Reckitt’s healthcare business.

1. Fybogel | Relieve Constipation with Our Fibre Supplements
2. FYBOGEL Trademark – UK Trademark Application UK0001003768A
3. FYBOGEL Canada Trademark Filing & Registration | Canadian Trademark Search
4. FYBOGEL – Drug – RxReasoner
5. Package insert
6. FYBOGEL
7. Manage Your Gut Symptoms with Senokot, Fybogel and FyboCalm
8. Fybogel Hi-Fibre Lemon patient information